Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. March 07, 2019. Mark Day

Executive Summary

Electrocardiography (ECG) trial data by iRhythm Technologies Inc.'s Zio ambulatory continuous-care wearable ECG monitor analyzed by artificial intelligence showed that it can detect cardiac arrhythmias as effectively as a panel of expert cardiologists. See what iRhythm's EVP for R&D Mark Day said about it here.

"Two weeks represents about 1.5 million heartbeats, but a patients’ arrhythmia may only appear in as few as 10 of those heartbeats.That's a problem that AI is really well suited to address." – Mark Day, Executive Vice President of Research & Development, iRhythm

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts